Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Orchestra BioMed
AddedFeb 15, 2024
UpdatedJul 5, 2026
Orchestra BioMed

Orchestra BioMed

Acquired

Caliber Therapeutics develops and commercializes balloon-based drug delivery products for atherosclerotic diseases.

HQ
New Hope, PA, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Caliber Therapeutics, founded to address the needs of patients with atherosclerotic diseases, focuses on developing and commercializing minimally-invasive balloon-based drug delivery products. Their core mission is to provide innovative solutions that enable controlled and targeted drug delivery, thereby reducing thrombosis risk and the need for permanent implants. The company's flagship product, the Targeted Angioplasty Drug Delivery balloon, exemplifies this mission by offering a stent-free platform for anti-restenotic drugs.

Notable affiliated people include key figures in biomedical innovation and strategic partnerships with leading medical device companies. Caliber Therapeutics has achieved significant milestones in advancing their therapeutic pipeline and forming risk-reward sharing partnerships to accelerate global commercialization. Their impact is marked by the potential to transform the treatment landscape for atherosclerotic diseases, improving patient outcomes through innovative drug delivery solutions.

Orchestra BioMed - Similar Companies

Talima Therapeutics logo

Talima Therapeutics

talima.com

Stealth Therapeutics logo

Stealth Therapeutics

Mechano-Therapeutics logo

Mechano-Therapeutics

Bioabsorbable Therapeutics logo

Bioabsorbable Therapeutics

Underdog Pharmaceuticals logo

Underdog Pharmaceuticals

cyclaritytx.com

Theracos logo

Theracos

theracos.com

Theradaptive logo

Theradaptive

theradaptive.com

Thrombolex logo

Thrombolex

thrombolex.com

Intact Therapeutics logo

Intact Therapeutics

Advanced Catheter Therapies logo

Advanced Catheter Therapies

acatheter.com

Edulis Therapeutics logo

Edulis Therapeutics

edulis.xyz

Anthos Therapeutics logo

Anthos Therapeutics

CeleCor Therapeutics logo

CeleCor Therapeutics

celecor.com

Embolx logo

Embolx

embolx.com

Concentric Analgesics logo

Concentric Analgesics

Orchestra BioMed - Quick Facts

Who are Orchestra BioMed's competitors?

Companies similar to Orchestra BioMed include Talima Therapeutics, Stealth Therapeutics, Mechano-Therapeutics and Bioabsorbable Therapeutics.

When was Orchestra BioMed founded?

Orchestra BioMed was founded in 2005.

Where is Orchestra BioMed's headquarters located?

Orchestra BioMed's headquarters is located in New Hope, PA, US.

When was Orchestra BioMed's last funding round?

Orchestra BioMed's most recent funding round was for $12M (USD) in June 2017.

How much has Orchestra BioMed raised to-date?

As of Jun 13, 2017, Orchestra BioMed has raised a total of $12M (USD).

Orchestra BioMed - Classification

Ownership
  • Private
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Delivery
Tags
  • SaaS
Unique IDs
  • secCik: 0001814114
  • ticker: OBIO
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified